Physician profile
Emily Davis
NPI 1750785051
$1,189.62
in general payments reported to CMS, 2019-2025
17 companies · $14.23 in 2025
The $14.23 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $58.12 · 2022: $428 · 2023: $362 · 2024: $327 · 2025: $14.23.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $673 · Long Term Medical Supply Or Device Loan: $29.97.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $673.29 |
| Long Term Medical Supply Or Device Loan | $29.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $502.09 | 2021-2024 | Ozempic, Wegovy |
| Dexcom, INC. | $183.65 | 2021-2025 | Dexcom G6 Transmitter |
| Abbott Laboratories | $96.43 | 2023-2024 | Freestyle Libre 3, Freestyle Insulinx |
| Sanofi-Aventis U.S. LLC | $56.83 | 2022-2024 | |
| Cequr Corporation | $47.76 | 2022-2024 | Cequr Simplicity |
| Horizon Therapeutics Plc | $41.90 | 2023 | Tepezza |
| Amgen INC. | $40.35 | 2024 | Evenity, Prolia |
| Bayer Healthcare Pharmaceuticals INC. | $32.00 | 2022 | |
| Radius Health, INC. | $29.60 | 2023 | Tymlos |
| Boehringer Ingelheim Pharmaceuticals, INC. | $28.75 | 2024 | Jardiance |
| Eisai INC. | $23.72 | 2024 | |
| Insulet Corporation | $21.89 | 2024 | Omnipod |
| Lilly USA, LLC | $21.33 | 2023 | Jardiance |
| Amphastar Pharmaceuticals, INC. | $17.57 | 2024 | Baqsimi |
| Rgh Enterprises LLC | $17.53 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $14.11 | 2024 | Minimed 780g |
| Amarin Pharma, INC. | $14.11 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Emily Davis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.